Use of new T-cell-based cell lines expressing two luciferase reporters for accurately evaluating susceptibility to anti-human immunodeficiency virus type 1 drugs.

Source:http://linkedlifedata.com/resource/pubmed/id/17182760

Download in:

View as

General Info

PMID
17182760